Gene Variant and Breast Cancer in Black Women
April 3, 2019
A set of gene variants that originated in Sub-Saharan West African populations may help explain why black women, compared to white women, have worse breast cancer outcomes, according to a new study from a team led by researchers at Weill Cornell Medicine and NewYork-Presbyterian.
Nanovaccine boosts immunity in sufferers of metabolic syndrome
March 27, 2019
EIPM Member Ankur Singh, assistant professor in the Sibley School of Mechanical and Aerospace Engineering (MAE) and the Meinig School of Biomedical Engineering (BME), and Matthew Mosquera, an EIPM visiting team member and doctoral student in engineering, along with partners from Cornell University in Ithaca published a very interesting paper on how their nanovaccing aids people with metabolic syndrome. The following article is from Cornell Chronicle.
A Conversation with Jenny Xiang, M.D.
March 26, 2019
As its founding Director, Dr. Xiang has led the GRCF since 2000 and provides state-of-the-art services in genomics and related high throughput technologies to the basic and translational research and clinical communities at WCM, Cornell University, NewYork-Presbyterian Hospital, the Hospital for Special Surgery, and external collaborators.
New Target for Aggressive Prostate Cancer
March 25, 2019
A study by the Englander Institute for Precision Medicine members including first author Loredana Puca, Ph.D., a postdoctoral fellow in the laboratory of Himisha Beltran, M.D., published an important new manuscript in Science Translational Medicine last week demonstrating the feasibility of targeting neuroendocrine prostate cancer, an aggressive prostate cancer subtype, with an antibody-drug conjugate against delta-like protein 3 (DLL3).
Introducing Dr. Wael Al Zoughbi
March 19, 2019
Dr. Al Zoughbi is a certified anatomic pathologist with experience in translational molecular oncology. For the last ten years he has been applying his skills in pathology at the interface between medicine, science, and enterprise to guide precision cancer medicine and tissue-based biomarker discovery.
What makes your research unique?
It is the integrated system of experience in clinical applications and technology innovation that will shape the future of medicine. Hence, I am excited to be here at the Englander Institute for Precision Medicine (EIPM).
The Role of Advanced Genomics in Dermatology
February 20, 2019
Dr. Anandasabapathy is an Associate Professor of Dermatology and is affiliated with the Meyer Cancer Center’s Immuno-Oncology Working Group. As a physician-scientist in dermatology studying the immune surveillance of barrier tissues and tumor, her work is focused on the cross-talk between T cells and dendritic cells, and the co-opting of tissue specific programs in the tumor microenvironment.
The Urgent Need for Better Stroke Care
February 7, 2019
We are pleased to introduce you to Hye-Yeon Choi, M.D., M.S., Ph.D., a stroke neurologist from Seoul, South Korea. Dr. Choi is a visiting Assistant Professor of Physiology and Biophysics at Weill Cornell Medicine and a new Member of the Englander Institute for Precision Medicine.
Please Welcome Cora Sternberg, M.D.
January 25, 2019
The Englander Institute for Precision Medicine (EIPM) is excited to announce that world-renowned medical oncologist Cora Sternberg, M.D., has joined our staff as Clinical Director.
Machine Learning and the Immunopeptidome
January 8, 2019
Kevin Michael Boehm and colleagues from the Englander Institute for Precision Medicine at Weill Cornell Medicine have just published a new paper on how machine learning can be used to expand our understanding of the immunopeptidome.
The new paper, “Predicting peptide presentation by major histocompatability complex class I: an improved machine learning approach to the immunopeptide,” was published on January 5, 2019 in BMC Bioinformatics.
The Power of Collaboration
December 24, 2018
Collaborations between the Englander Institute for Precision Medicine (EIPM), Cornell University in Ithaca, and Cornell Tech are important to the future of precision medicine. To highlight the intellectual rewards of collaboration, we are pleased to introduce two young Ph.D. students from Cornell University who are spending significant time at the EIPM in New York City working on cutting-edge research projects.
Question: Please tell our readers about your research.